Hetlioz is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Vanda Pharmaceuticals Inc.. The primary component is Tasimelteon.
Product ID | 43068-220_046bf85f-3017-415f-a709-4d849c8d2744 |
NDC | 43068-220 |
Product Type | Human Prescription Drug |
Proprietary Name | Hetlioz |
Generic Name | Tasimelteon |
Dosage Form | Capsule |
Route of Administration | ORAL |
Marketing Start Date | 2014-04-04 |
Marketing Category | NDA / NDA |
Application Number | NDA205677 |
Labeler Name | Vanda Pharmaceuticals Inc. |
Substance Name | TASIMELTEON |
Active Ingredient Strength | 20 mg/1 |
Pharm Classes | Melatonin Receptor Agonist [EPC],Melatonin Receptor Agonists [MoA] |
NDC Exclude Flag | N |
Listing Certified Through | 2021-12-31 |
Marketing Start Date | 2014-04-04 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA205677 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2014-04-04 |
Ingredient | Strength |
---|---|
TASIMELTEON | 20 mg/1 |
SPL SET ID: | ca4a9b63-708e-49e9-8f9b-010625443b90 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI | |
UPC Code |
NDC | Brand Name | Generic Name |
---|---|---|
43068-220 | Hetlioz | tasimelteon |
43068-304 | Hetlioz | tasimelteon |
0480-4490 | Tasimelteon | Tasimelteon |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
HETLIOZ 97791877 not registered Live/Pending |
Vanda Pharmaceuticals Inc. 2023-02-13 |
HETLIOZ 88981892 not registered Live/Pending |
Vanda Pharmaceuticals Inc. 2019-04-01 |
HETLIOZ 88366716 not registered Live/Pending |
Vanda Pharmaceuticals Inc. 2019-04-01 |
HETLIOZ 85383242 4552099 Live/Registered |
Vanda Pharmaceuticals Inc. 2011-07-28 |